Potential clinical utility of gene-expression profiling in identifying tumors of uncertain origin

Personalized Medicine

Volumn 8, Issue 6, 2011, Pages 615-622

  Laouri, Marianne ^a   Halks Miller, Meredith ^b   Henner, W David ^b   Nystrom, J Scott ^c  

^a Quorum Consulting Inc   (United States)

^b Pathwork Diagnostics   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

cancer of uncertain origin; gene expression test; tissue of origin

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER OF UNKNOWN PRIMARY SITE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; PRIMARY TUMOR; PRIORITY JOURNAL; TISSUE FIXATION; TREATMENT PLANNING;

EID: 80755189414     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.11.65     Document Type: Article

References (17)

1. Pavlidis N, Fizazi K. Cancer of unknown primary (CUP). Crit. Rev. Oncol. Hematol. 54, 243-350 (2005).
2. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur. J. Cancer 39, 1990-2005 (2003). (Pubitemid 37297755)
3. Varadhachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer 100, 1776-1785 (2004). (Pubitemid 38529553)
4. Bahrami A, Truong LD, Ro JY. Undifferentiated tumor: true identity by immunochemistry. Arch. Pathol. Lab. Med. 132, 326-348 (2008). (Pubitemid 351328809)
5. Brown RW, Campagna LB, Dunn JK, Cagle PT. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site. Am. J. Clin. Pathol. 107, 12-19 (1997). (Pubitemid 27104630)
6. Sica G, Wagner PL, Altorki N et al. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors. Arch. Pathol. Lab. Med. 132, 1889-1895 (2008).
7. Anderson GG, Weiss L. Determining tissue of origin for metastatic cancers: meta-analysis and literature review of immunohistochemistry performance. Appl. Immunohistochem. Mol. Morphol. 1, 3-8 (2010).
8. Bugat R, Bataillard A, Lesimple T et al. Summary of the standards, options and recommendations for the management of patients with carcinoma of unknown primary site (2002). Br. J. Cancer 89(Suppl. 1), S59-S66 (2003). (Pubitemid 37076150)
9. Monzon FA, Lyons-Weiler M, Buturovic L et al. Multicenter validation of a 1,550-gene expression profile for identification of tumor tissue of origin. J. Clin. Oncol. 27, 2503-2508 (2009).
10. Pillai R, Deeter R, Rigl CT et al. Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens. J. Mol. Diag. 13, 48-56 (2011).
11. Erlander MG, Ma XJ, Kesty NC et al. Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification. J. Mol. Diagn. 13, 493-503 (2011).
12. Varadhachary GR, Spector Y, Abbruzzese JL et al. Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary (CUP). Clin. Cancer Res. 17, 4063-4070 (2011).
13. Monzon FA, Koen TJ. Diagnosis of metastatic neoplasms: molecular approaches for identification of tissue of origin. Arch. Pathol. Lab. Med. 134, 216-224 (2010).
14. Al-brahim N, Ross C, Carter B, Chorneyko K. The value of postmortem examination in cases of metasasis of unknown origin - 20 year retrospective data from a tertiary care center. Ann. Diag. Pathol. 9, 77-80 (2005). (Pubitemid 40460741)
15. Mayordomo JI, Guerra JM, Guijarro C et al. Neoplasms of unknown primary site: a clinicopathological study. Tumori 79, 321-324 (1993). (Pubitemid 24098931)
16. Nystrom JS, Weiner JM, Heffelfinger-Juttner J, Irwin LE, Bateman JR, Wolf RM. Metastatic and histologic presentations in unknown primary cancer. Semin. Oncol. 4, 53-58 (1977). (Pubitemid 8070999)
17. Hornberger J, Amin M, Varadhachary G, Henner WD, Nystrom JS. Effect of a gene expression-based Tissue of Origin Test on patient management for difficult-to-diagnose primary cancers [Poster]. Presented at: ASCO 2011 Gastrointestinal Cancers Symposium. 20-22 January (2011).